SCHEMBL4240982

SCHEMBL4240982

N=C(NOC(=O)C(F)(F)F)NC(=O)c1cn(-c2ccnc3ccc(F)cc23)c2ccccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 2/20 0.34
MALT1 Q9UDY8 4/20 0.33
CDK8 P49336 2/20 0.33
CLK2 P49760 1/20 0.33
ACVR1 Q04771 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
MET P08581 1/20 0.32
KIT P10721 1/20 0.32
FLT3 P36888 1/20 0.32
RORA P35398 1/20 0.32
NR2E1 Q9Y466 1/20 0.32
HTR3A P46098 2/20 0.31
CCNC P24863 1/20 0.31
SCN9A Q15858 1/20 0.31
KMT2A Q03164 1/20 0.31
IDO1 P14902 2/20 0.31
CYP8B1 Q9UNU6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4240979 0.86 L3MBTL1 (0.35) ROCK1MALT1CDK8CLK2ACVR1
SCHEMBL4241091 0.86 NTSR1 (0.42) KMT2ANTSR1
SCHEMBL4240870 0.86 ROCK1 (0.37) ROCK1MALT1CDK8CLK2ACVR1
SCHEMBL4247339 0.84 MALT1 (0.35) ROCK1MALT1CLK2CLK4FLT3
SCHEMBL4245169 0.78 MALT1 (0.37) ROCK1MALT1CDK8CCNCIDO1
SCHEMBL4243183 0.78 PIK3R2 (0.37) KMT2ARAB9ASMN1; SMN2
SCHEMBL4242771 0.78 MALT1 (0.34) MALT1HTR3ASCN9AIDO1
SCHEMBL4245425 0.78 TNFSF11 (0.39) MALT1CDK8CLK2CLK4RORA
Hydrochloric Acid SCHEMBL4240291 0.78 MALT1 (0.36) ROCK1MALT1CDK8CCNCIDO1
Hydrochloric Acid SCHEMBL4237204 0.77 TNFSF11 (0.39) MALT1CDK8CLK2CLK4RORA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638521-B2 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2009-12-29 US disclosed